Stock Trend Analysis Report
Prepared for you on Tuesday, July 5, 2022.
Recursion Pharmaceuticals, Inc. - Class A (NASDAQ:RXRX)
Bull Market Weakness (+75) - RXRX is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on RXRX as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid RXRX?
MarketClub looks at technical strength and momentum to determine if the timing is right for RXRX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for RXRX
The long-term trend has been DOWN since Aug 17th, 2021 at 19.68
The intermediate-term trend has been UP since May 31st, 2022 at 6.19
The short-term trend has been UP since Jul 1st, 2022 at 8.49
Smart Scan Analysis for RXRX
Based on our trend formula, RXRX is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||42.81||52wk High Date||2021-07-13|
|52wk Low||4.92||52wk Low Date||2022-05-12|
|Average Volume||1,172,138||Shares Outstanding||172,007|